
Inogla-M 500 Tablet PR
Marketer
Wockhardt Ltd
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Inogla-M 500 Tablet PR
DiabetaComb 500mg (extended-release) combines two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. DiabetaComb 500mg may be used alone or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and existing medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Effective blood sugar control prevents future complications. Continued commitment to your doctor's dietary and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, and cephalalgia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn its recognition and management. This medication isn't appropriate for all individuals. Prior to use, disclose any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel. Inform your doctor of all medications you're taking to avoid interactions. Alcohol should be limited due to its potential to lower blood glucose. Your physician will monitor renal function and blood glucose levels before and throughout treatment.
Uses of Inogla-M 500 Tablet PR
Managing Type 2 Diabetes
Major Benefits of Inogla-M 500 Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Inogla-M 500 Tablet PR should be administered with a meal.
Common Side effects of Inogla-M 500 Tablet PR:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Inogla-M 500 Tablet PR:
Follow your doctor's instructions or refer to the package insert for proper administration. Take Inogla-M 500 Tablet PR with a meal.
How Inogla-M 500 Tablet PR works:
Inogla-M 500 PR tablets contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol ingestion and Inogla-M 500 Tablet PR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Inogla-M 500 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Inogla-M 500 Tablet PR while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Inogla-M 500 Tablet PR on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should use Inogla-M 500 Tablet PR with care; dosage modification may be necessary. Consult your physician for guidance. Inogla-M 500 Tablet PR is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverUNSAFE
The use of Inogla-M 500 Tablet PR is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Inogla-M 500 Tablet PR :
Should you forget to take your Inogla-M 500 Tablet PR, ingest the missed dose immediately if possible. If, however, your next scheduled dose is imminent, omit the forgotten dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Inogla-M 500 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
